Nasdaq · CIK 0001638911
DUKR DUKE Robotics Corp.
Insider trading from SEC Form 4. Last filing 7 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
8
with a Form 4 at this company
Signals
Open-market buys and sells at DUKE Robotics Corp., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 13 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Avi Levin CHIEF FINANCIAL OFFICER | AGrant or award Option to Purchase Common Stockderivative | +35,000 | $0.00 | $0 | 35,000 | 7 d ago |
| Oct 5, 2026 | Yiftach Kleinman CHIEF EXECUTIVE OFFICER | AGrant or award Option to Purchase Common Stockderivative | +53,600 | $0.00 | $0 | 53,600 | 7 d ago |
| Oct 5, 2026 | Erez Nachtomy director | AGrant or award Option to Purchase Common Stockderivative | +28,000 | $0.00 | $0 | 28,000 | 7 d ago |
| Oct 5, 2026 | Vadim Maor CHIEF TECHNOLOGY OFFICER | AGrant or award Option to Purchase Common Stockderivative | +28,000 | $0.00 | $0 | 28,000 | 7 d ago |
| Mar 10, 2026 | Eran Antebi director | AGrant or award Option to Purchase Common Stockderivative | +4,000 | $0.00 | $0 | 4,000 | Mar 17, 2026 |
| Mar 10, 2026 | Yossef Balucka CHIEF EXECUTIVE OFFICER | AGrant or award Option to Purchase Common Stockderivative | +16,000 | $0.00 | $0 | 16,000 | Mar 12, 2026 |
| Mar 10, 2026 | Erez Nachtomy director | AGrant or award Option to Purchase Common Stockderivative | +16,000 | $0.00 | $0 | 16,000 | Mar 12, 2026 |
| Mar 10, 2026 | Vadim Maor CHIEF TECHNOLOGY OFFICER | AGrant or award Option to Purchase Common Stockderivative | +4,000 | $0.00 | $0 | 4,000 | Mar 12, 2026 |
| Mar 10, 2026 | Keren Gousman Golan director | AGrant or award Option to Purchase Common Stockderivative | +4,000 | $0.00 | $0 | 4,000 | Mar 12, 2026 |
| Mar 10, 2026 | Shlomo Zakai CHIEF FINANCIAL OFFICER | AGrant or award Option to Purchase Common Stockderivative | +10,000 | $0.00 | $0 | 10,000 | Mar 12, 2026 |
| Mar 18, 2025 | Yossef Balucka CHIEF EXECUTIVE OFFICER | AGrant or award Option to Purchase Common Stockderivative | +1,000,000 | $0.00 | $0 | 1,000,000 | Mar 20, 2025 |
| Mar 18, 2025 | Vadim Maor Chief Technology Officer | AGrant or award Option to Purchase Common Stockderivative | +500,000 | $0.00 | $0 | 500,000 | Mar 20, 2025 |
| Mar 18, 2025 | Shlomo Zakai CHIEF FINANCIAL OFFICER | AGrant or award Option to Purchase Common Stockderivative | +50,000 | $0.00 | $0 | 50,000 | Mar 20, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Eran Antebidirector
- Yossef BaluckaCHIEF EXECUTIVE OFFICER
- Keren Gousman Golandirector
- Yiftach KleinmanCHIEF EXECUTIVE OFFICER
- Avi LevinCHIEF FINANCIAL OFFICER
- Vadim MaorCHIEF TECHNOLOGY OFFICER
- Erez Nachtomydirector
- Shlomo ZakaiCHIEF FINANCIAL OFFICER
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.